US Stock MarketDetailed Quotes

PSTV Plus Therapeutics

Watchlist
  • 1.7500
  • +0.0100+0.57%
Close Jul 22 16:00 ET
  • 1.7600
  • +0.0100+0.57%
Post 17:24 ET
9.98MMarket Cap-599P/E (TTM)

Plus Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Plus Therapeutics Earnings Date

Currency: USD

Period

Q1 FY2024 Earnings

May 15, 2024

Revenue(YoY)

0.00

0.00%
EPS(YoY)

-0.75

+63.77%
Analyst Rating

Strong Buy

Jun 30, 2024

Plus Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 1.117M--
--2024/Q2-- / 1.117M--
May 15, 20242024/Q11.677M / 1.688M--
Mar 5, 20242023/Q41.313M / 850.670K--
Oct 31, 20232023/Q31.240M / 1.158M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 1.117M--
--2024/Q2-- / 1.117M--
May 15, 20242024/Q11.677M / 1.688M--
Mar 5, 20242023/Q41.313M / 850.670K--
Oct 31, 20232023/Q31.240M / 1.158M--

Unlock Free Earnings Estimates

Plus Therapeutics Earnings Reports

  • Plus Therapeutics | 10-Q: Quarterly report

    May 15 16:12 ET

  • Plus Therapeutics | 10-K: Annual report

    Mar 5 16:03 ET

  • Plus Therapeutics | 10-Q: Q3 2023 Earnings Report

    Oct 31, 2023 16:02 ET

  • Plus Therapeutics | 10-Q: Q2 2023 Earnings Report

    Aug 14, 2023 16:02 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Jun 30, 2024

    Strong Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    %Chg